The expression level of ligands for natural killer cell receptors predicts response to bacillus Calmette-Guerin therapy: a pilot study
- PMID: 17945285
- DOI: 10.1016/j.juro.2007.07.118
The expression level of ligands for natural killer cell receptors predicts response to bacillus Calmette-Guerin therapy: a pilot study
Abstract
Purpose: Up to 90% of patients with high grade superficial bladder tumors experience tumor recurrence and up to 50% have progression despite bacillus Calmette-Guerin treatment. Natural killer cells have a major role in the mechanism of the response to bacillus Calmette-Guerin but the exact mechanisms are still elusive. The recently discovered natural cytotoxicity receptors are linked to the host response to viral infection and to cancer. We tested the hypothesis that tumor expression of natural cytotoxicity receptor ligands can serve as a predictive factor for the response to intravesical bacillus Calmette-Guerin in patients with nonmuscle invasive, high grade bladder cancer.
Materials and methods: We developed a histochemical staining method for analysis of the ligands of the 3 known natural cytotoxicity receptors NKp30, NKp44 and NKp46 using genetically engineered fusion proteins and an automated image analysis system. We examined formalin fixed, paraffin embedded sections of specimens of transurethral bladder tumor resection from patients with primary, nonmuscle invasive, high grade bladder cancer who were subsequently treated with bacillus Calmette-Guerin. We compared natural cytotoxicity receptor ligand expression to the response to bacillus Calmette-Guerin immunotherapy.
Results: Six of 17 patients (35%) had recurrence despite bacillus Calmette-Guerin treatment. Primary tumors from favorably responding patients expressed higher levels of ligands for all 3 fusion proteins (NKp30, NKp44 and NKp46 p = 0.0026, 0.027 and 0.044, respectively).
Conclusions: Bacillus Calmette-Guerin resistant, high grade, nonmuscle invasive bladder tumors express significantly lower levels of ligands of all 3 natural cytotoxicity receptors compared with bacillus Calmette-Guerin responsive tumors. This suggests that down-regulation of these ligands facilitates escape from the bacillus Calmette-Guerin effect. Furthermore, analysis of ligand expression, which can be performed on formalin fixed, paraffin embedded sections, may serve as a new predictive assay for the response to bacillus Calmette-Guerin.
Comment in
-
Predicting bacillus Calmette-Guerin immunotherapy effectiveness.J Urol. 2007 Dec;178(6):2247-8. doi: 10.1016/j.juro.2007.08.075. Epub 2007 Oct 22. J Urol. 2007. PMID: 17936825 No abstract available.
Similar articles
-
Bladder tumor infiltrating mature dendritic cells and macrophages as predictors of response to bacillus Calmette-Guérin immunotherapy.Eur Urol. 2009 Jun;55(6):1386-95. doi: 10.1016/j.eururo.2009.01.040. Epub 2009 Feb 3. Eur Urol. 2009. PMID: 19193487
-
An analysis of the effect of statin use on the efficacy of bacillus calmette-guerin treatment for transitional cell carcinoma of the bladder.J Urol. 2008 Oct;180(4):1297-300; discussion 1300. doi: 10.1016/j.juro.2008.06.034. Epub 2008 Aug 15. J Urol. 2008. PMID: 18707737
-
Recurrence, progression and success in stage Ta grade 3 bladder tumors treated with low dose bacillus Calmette-Guerin instillations.J Urol. 2000 Jan;163(1):63-7. J Urol. 2000. PMID: 10604315 Clinical Trial.
-
The management of superficial bladder cancer.Nat Clin Pract Urol. 2007 May;4(5):254-60. doi: 10.1038/ncpuro0784. Nat Clin Pract Urol. 2007. PMID: 17483810 Review.
-
The value of transurethral bladder biopsy after intravesical bacillus Calmette-Guérin instillation therapy for nonmuscle invasive bladder cancer: a retrospective, single center study and cumulative analysis of the literature.J Urol. 2012 Sep;188(3):748-53. doi: 10.1016/j.juro.2012.05.015. Epub 2012 Jul 20. J Urol. 2012. PMID: 22819422 Review.
Cited by
-
NKG2D is a Key Receptor for Recognition of Bladder Cancer Cells by IL-2-Activated NK Cells and BCG Promotes NK Cell Activation.Front Immunol. 2015 Jun 8;6:284. doi: 10.3389/fimmu.2015.00284. eCollection 2015. Front Immunol. 2015. PMID: 26106390 Free PMC article.
-
Alternatively spliced NKp30 isoforms affect the prognosis of gastrointestinal stromal tumors.Nat Med. 2011 Jun;17(6):700-7. doi: 10.1038/nm.2366. Epub 2011 May 8. Nat Med. 2011. PMID: 21552268
-
Mathematical model of tumor immunotherapy for bladder carcinoma identifies the limitations of the innate immune response.Oncoimmunology. 2012 Jan 1;1(1):9-17. doi: 10.4161/onci.1.1.17884. Oncoimmunology. 2012. PMID: 22720207 Free PMC article.
-
Innate Lymphoid Cells in Bladder Cancer: From Mechanisms of Action to Immune Therapies.Cancer Immunol Res. 2024 Feb 2;12(2):149-160. doi: 10.1158/2326-6066.CIR-23-0414. Cancer Immunol Res. 2024. PMID: 38060011 Free PMC article. Review.
-
High mannose level in bladder cancer enhances type 1 fimbria-mediated attachment of uropathogenic E. coli.Front Cell Infect Microbiol. 2022 Aug 31;12:968739. doi: 10.3389/fcimb.2022.968739. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 36118038 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical